Pathogenic FLA are ubiquitous protozoans and despite frequent human contact remain a rare cause of often devastating infection with poor prognosis. Given changes in climate, human encroachment into the environment, increasing immunosuppression, and improving diagnostic capacity, it is likely we will see increased cases in the future. Early diagnosis is challenging but crucial to achieving a favourable outcome. It is best facilitated by improved awareness of FLA disease, appropriate clinical suspicion and early diagnostic testing.
Free living amoebae (FLA) are a cosmopolitan group of protozoan organisms that do not require a host to survive. Despite their ubiquitous nature, these organisms are uncommon human pathogens. However, four genera contain species known to cause invasive disease in humans: Acanthamoeba, Naegleria, Balamuthia and Sappinia. Acanthamoeba infections may present as granulomatous amoebic encephalitis (GAE), disseminated disease (e.g. cutaneous, sinus or pulmonary infection) or keratitis, with Balamuthia mandrillaris causing similar cutaneous infections and GAE. Naegleria This review aims to provide an overview of human disease caused by the three most common genera involved, Acanthamoeba, Naegleria and Balamuthia, including their laboratory diagnosis.
Epidemiology
Pathogenic FLA are found worldwide and serological studies suggest human exposure is common [3] [4] [5] . Three cases of Acanthamoeba GAE have been described in Australia [6] [7] [8] . Acanthamoeba sp tolerate a wide range of temperature, pH and osmolarity 9 and may be found in air, soil and water samples. They are one of the most commonly isolated FLA in the environment 10 , and the most common in human infection 2 . The strongest risk factor for GAE or disseminated infection is immunodeficiency, while keratitis most commonly affects immunocompetent contact lens wearers who often have a history of poor lens hygiene. Exposure is thought to occur by inhalation, mucosal contact or direct inoculation 10 . Acanthamoeba species were previously classified based on morphology, but are now grouped into 17 genotypes based on 18S rRNA sequencing, with the majority of pathogenic species belonging to the T4 genotype 9, 11 . Naegleria fowleri may be found in rivers, lakes and soil but does not survive in sea water. As thermophiles, their presence in fresh water is related to temperature and they may even be recovered from thermally polluted waters at high latitudes 12 . Human exposure occurs through contact with intact or disrupted nasal mucosa, commonly through recreational or nasal ablution practices 13 and contaminated drinking water has been implicated as a source of infection in some cases 14 . Australia has featured prominently in the history of Naegleria fowleri infection, with cases described in 
Naegleria fowleri
Naegleria fowleri causes primary amoebic meningoencephalitis.
Symptoms generally occur 2-5 days after exposure and may begin with changes in taste or smell, followed by fever, nausea, vomiting, photophobia and headache. The disease is fulminant, with rapid progression to coma and death.
Balamuthia mandrillaris
Balamuthia Under the Microscope differentiate each of these amoebae in tissue specimens 28 (as can molecular methods), though availability is limited to the CDC, Atlanta, USA.
In Acanthamoeba keratitis, a diagnosis may be made by demonstrating trophozoites and/or cysts in corneal samples. It is possible to directly identify Acanthamoeba trophozoites within the cornea using confocal microscopy and in experienced hands this technique is sensitive and specific 29 . Trophozoites and cysts may be revealed by staining the smear with H&E or Giemsa, while cysts are also readily identified using PAS and fluorescent stains, such as calcofluor white and acridine orange 30 . On occasion, non-specific fluorescence or binding to fungi in mixed infections can lead to diagnostic errors 31 , especially when used by inexperienced microscopists.
Culture
Samples intended for amoebic culture should be kept at room temperature and processed as quickly as possible. Freezing should be avoided, particularly for samples where Naegleria is suspected (the cyst stage is more fragile), as this compromises organism viability. Naegleria fowleri and Acanthamoeba sp. (Figure 1c ) can be readily cultured using non-nutrient media containing live or killed non-mucoid bacteria (usually E. coli or Enterobacter sp) as a food source 32 . Acanthamoeba and Naegleria will cover the agar surface in 1-2 days when incubated at 378C and their presence can be confirmed by examination of the plate with a plate microscope, or by performing microscopy of a wet mount from the agar plate.
Balamuthia do not appear to use bacteria as a food source and therefore cannot be cultivated in the same fashion 32 . They may be successfully cultured using axenic and tissue culture methods 32 , however with generation times of around 25 h, culture is a lengthy process and not part of routine diagnostic testing.
Nucleic acid testing
The use of molecular testing to diagnose and confirm infections with FLA has transformed diagnostics in this area. It allows more rapid diagnosis, with greater sensitivity than other methods and reduces the requirement for specialist, experienced staff to discern subtle microscopic features. Most molecular assays use ribosomal genes, such as the 18S rRNA or ITS repeat regions, as targets for PCR. However, as requests are infrequent, these tests are generally only offered by reference or research laboratories. Of particular note is a multiplex PCR, described by Qvarnstrom et al. 33 . This assay uses 18S rRNA primer/probe sets to accurately identify Acanthamoeba to the genus level and Naegleria fowleri and Acanthamoeba result. The referred CSF specimen tested negative at our laboratory, but positive at the CDC (using the same multiplex PCR). It is possible the small volume of CSF received at our laboratory contributed to this result (only 100 mL was received, where 200 mL is the standard volume for extraction).
Treatment and prognosis
Primary amoebic meningitis 
Granulomatous amoebic encephalitis Acanthamoeba
Suboptimal efficacy of antimicrobial agents, the high morbidity of patients affected and tendency to late diagnosis contribute to a poor prognosis in Acanthamoeba GAE, with a mortality rate of 
Balamuthia
Early recognition of cutaneous disease is critical to allow early therapy and prevent progression to CNS infection. Unfortunately, the overall prognosis in Balamuthia CNS infection is extremely poor. However, there are several case reports of survival in the literature 36 , including an Australian case 24 . These cases have received varied combination therapy regimens, with agents including pentamidine, flucytosine, fluconazole, macrolides, sulfadiazine, miltefosine, thioridazine, amphotericin B, albendazole and trimethoprim-sulfamethoxazole. Miltefosine, in particular, has demonstrated amoebicidal activity in vitro 37 and its inclusion in combination regimens may offer a survival advantage 35 .
Acanthamoeba keratitis
Like disseminated disease, success in treatment is dependent on early diagnosis and institution of therapy. Fortunately, success rates in treating Acanthamoebic keratitis are more promising, with cure rates in the literature generally greater than 75-85% 38, 39 .
Topical chlorhexidine and polyhexamethylenebiguanide (PHMB)
are effective against trophozoites and cysts and form the mainstay of therapy. These are usually used in combination with diamidine, propamidine or hexamidine, though other agents including ketoconazole, itraconazole, voriconazole and topical imidazoles have been used. Surgical intervention, including enucleation, is sometimes required in severe cases 40 .
